A recent study has shown that fertility preservation and assisted reproductive technologies (ART) can be safely used by patients with HR-positive breast cancer. Findings revealed that these treatments do not increase the risk of cancer recurrence. This is encouraging news for young women diagnosed with breast cancer who wish to preserve their fertility options. They can confidently opt for procedures like egg or embryo freezing without fearing any detrimental effects on their health. ART technologies, which help in conceiving after cancer treatment, are also deemed safe for these patients. This study provides a ray of hope for patients, assuring them that pursuing fertility preservation is a viable option.
Fertility Preservation and ART Safe for HR-positive Breast Cancer Patients
Using fertility preservation and/or assisted reproductive technologies (ART) did not adversely impact the risk of recurrence in patients with HR-positive breast cancer, according to a recent study. This finding provides hope for young women diagnosed with breast cancer who want to pursue fertility preservation options. The study suggests that these patients can undergo treatments like egg or embryo freezing without an increased risk of their cancer returning. The use of ART technologies to conceive after cancer treatment also does not pose any danger to their health.
Latest from Blog
Manu Chopra, CEO of Karya Inc., emphasized the importance of utilizing artificial intelligence (AI) to reduce
Italy has decided to withdraw from China's Belt and Road Initiative, becoming the only G7 nation
Zerodha's top executives collectively received a remuneration of about ₹200 crore in the financial year 2022-23,
New research suggests that radiotherapy may not be necessary for many patients with ductal carcinoma in
The US Space Force's X-37B space plane is gearing up for its seventh mission, after landing
